Why attend?

HEART UK and Health Innovation East will be joined by clinical experts across primary and secondary care to spotlight the heightened focus on cholesterol in secondary prevention of cardiovascular disease (CVD) to help improve health outcomes in the region.


  • Patient story
  • Importance of CVD prevention and cholesterol overview for the East of England – how are we doing?
  • Primary care challenges in lipid management and opportunities for improvement
  • Exemplar delivery models proving to be significantly affective for patients and the NHS
  • Practical guides to support the implementation of the novel therapy inclisiran within primary care
  • Familial hypercholesterolaemia identification – where to begin and who to test

Through the day, we will hear from: patients, regional medical directorates, GPs with Special Interest in Cardiology, ICB Divisional Directors, Consultants in Metabolic Medicine, Consultants in Chemical Pathology, Clinical Biochemistry Service Leads, Clinical Scientists, Nurses, Pharmacists, ICB colleagues and service management teams and more.

What are the learning outcomes?

  • Build and embody a culture for shared local ownership of CVD Prevention and lipid aims across the East of England
  • Understand new opportunities to improve lipid management locally including effectively achieving QOF CHOL indicators and make best use of the latest guidelines and resources
  • Gain confidence in optimising hyperlipidaemia patients effectively and efficiently